dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Live vebinar

Sotsiaalministeerium · 20. juuli 2020
Viit
1.4-4/2271-1
Registreeritud
20. juuli 2020
Dokumendi liik
Sissetulev kiri
Adressaat
WHO
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-4 Kutsed ja kirjavahetus rahvusvahelistel seminaridel, konverentsidel jt üritustel osalemiseks
Toimik
1.4-4/2020
Vastutaja
Agnes Alajõe (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja väliskoostöö osakond)
Lahendamise tähtaeg
27. juuli 2020

Failid

  • 📎Agenda of Webinar on Blood Regulation_Final.pdf239 KB
  • 📎Concept note Webinar August 2020_ym_cp_ym reviewed ADGO (002)_cp.pdf149 KB
  • 📎E-kiri.pdf78 KB
  • 📎EST Letter_nomination_dp_ENG_edited.pdf123 KB

Sisu (failidest)

SCHEDULE OF LIVE WEBINAR ON “STRENGTHENING BLOOD SYSTEMS THROUGH EFFECTIVE BLOOD REGULATION” (WITH SIMULTANEOUS TRANSLATION INTO SIX WHO OFFICIAL LANGUAGES) 4 days, 3 hours per-day, 4 topics per-day 03-06 August 2020 WHO Related Material Time Proposed Topic Allocation Speakers (Min) Day 1, 3 August 2020, start at 13.00 CET Opening 5 WHO 1. Current Issues in development of blood and blood products/The Value of 55 WHO Consultant Blood and Blood Product and Elements of a National Blood Policy (WHO Jay Epstein Guidance) - https://www.who.int/bloodsafety/transfusion_services/nat_blood_pol/en / 40 EMRO 2. Review of Blood Regulatory Framework (EMRO experience) Yetmgetta Abdella ts for blood systems of countries in the WHO EMR.pdf 40 BRN 3. Functions of the blood regulator (prototype GBT, WHO Assessment Micha Nuebling Criteria) GBT+ (as available) odRegSystems.pdf Questions and answers of Day 1 40 Moderator Day 2, 4 August 2020, start at 13.00 CET 35 BRN 4. GMP for Blood Establishments Christian Schaerer GMP_Bloodestablish ments.pdf 5. Regulation of blood/blood components as essential medicines 35 BRN http://apps.who.int/medicinedocs/en/m/abstract/Js23322en/ Francisca Agbanyo 6. Blood product standards 35 AABB https://www.afsbt.org/images/accreditation_documents/AfSBT_Step_Wis Jed Gorlin e_Accreditation_Standards.pdf 35 AABB 7. Product testing Jed Gorlin https://www.who.int/ihr/publications/lqms/en/ 9789241548274_eng. pdf Questions and answers of Day 2 40 Moderator Day 3, 5 August 2020, start at 13.00 CET 8. Conduct of inspections 35 BRN https://www.who.int/medicines/areas/quality_safety/quality_assurance/Q Christian Schaerer ualitySystemRequirementsNationalGMPInspectoratesTRS902Annex8.pdf?u a=1 9. Prevention of Transfusion Transmissible Infections 40 BRN Selection of donors Micha Nuebling https://www.who.int/bloodsafety/ScreeningTTI.pdf 10. Prevention of Transfusion Transmissible Infections Laboratory testing https://www.who.int/ihr/publications/lqms/en/ 11. Elements of a hemovigilance system 35 IHN https://www.who.int/bloodsafety/haemovigilance/haemovigilance- Jo Wiersum (recorded guide/en/ presentation) https://www.cdc.gov/nhsn/PDFs/Biovigilance/BV-HV-protocol-current.pdf Questions and answers of Day 3 40 Moderator Day 4, 6 August 2020, start at 13.00 CET 60 Region/Country 12. Region/Country presentation (10 minutes each) 75 PEI Blood Train 13. Practical exercises (case studies) a. Jens Reinhardt a. Criteria for blood establishment qualification b. Washington b. Conduct of an inspection Samukange/Chancelar Kafere c. Joanna c. Risk prevention: e.g. emerging TTID/IVD etc. Atemnkeng/Kristina Heinrich/Herbert Mbunkah d. Principles of a Clinical trial concept for COVID-19 convalescent plasma d. Anneliese Hilger Questions and answers Day 4 40 Moderator Closing 5 WHO Concept Note WHO LIVE WEBINAR ON STRENGTHENING BLOOD SYSTEMS THROUGH EFFECTIVE BLOOD REGULATION 3-6 AUGUST 2020 Background A blood product is any therapeutic substance derived from human blood, including whole blood and other blood components for transfusion, and plasma derived medicinal products (PDMPs). Safe, effective and quality assured blood products contribute to improving and saving millions of lives every year. Access to blood products, which includes equitable availability and affordability, is imperative to safeguard public health. However, a major imbalance exists between higher- income and lower-income countries in access to safe, effective and quality assured blood products. WHO is strongly committed to the improvement of blood product safety, effectiveness and quality, and has provided a great number of guidelines, biological reference standards, training and technical support in past decades. Still, progress in blood regulation and availability has been slow in many parts of the world. For that reason, the WHO Action framework to advance universal access to safe, effective and quality-assured blood products 2020–2023 proposes a renewed effort to scale up programme implementation and improve access to blood products. The first challenge in ensuring access to safe blood products, that has been identified and listed in the Action framework is deficiencies in national policy, governance and financing. The GDBS 2015 showed that only 60-70% Member States reported the existence of a national blood regulatory framework, with regional variations. Member States Barriers to a well-functioning national blood system include, lack of political commitment and awareness of the essential role of a national blood system in the larger health system; inadequate legal and regulatory frameworks for a national blood system; and resource limitations. To address this challenge, an appropriately structured, well-coordinated and sustainably resourced national blood system should be established. A webinar on this aspect is needed to improve Member States knowledge and capacity to establish and sustain a national blood system that is integrated into the national health system, with clearly defined roles and accountabilities, and regulatory decision-making and governance frameworks. Objectives and Goals The Webinar is expected to improve country knowledge and capacity on how to strengthen blood systems through effective blood regulation. Page 1 of 2 During the live webinar the following topics/presentations are planned to be covered: (1) The Value of Blood and Blood Product and Elements of a National Blood Policy (2) Review of Blood Regulatory Framework: EMRO experience (3) Functions of the blood regulator (4) GMP for Blood Establishments (5) Regulation of blood/blood components as essential medicines (6) Blood product standards (7) Product testing (8) Conduct of inspections (9) Prevention of Transfusion Transmissible Infections: a) selection of donors (10) Prevention of Transfusion Transmissible Infections: b) laboratory testing (11) Elements of a hemovigilance system (12) Country experience in building blood regulation Expected outcomes: Blood regulators from each country in coordination with Blood Establishment will be able to build effective blood regulation as an effort to strengthen national blood system. Participants: (1) Blood regulators officials from the Ministry of Health (2) Responsible person for National Blood Programmes (3) Directors of the major Blood Establishments Webinar scenario: This is a Four-day Live Webinar in English that will be translated simultaneously into all six WHO official languages. The recordings of the webinar will be posted on the website. Each day, the Webinar will start at 13.00 CET, with 4 topics in 3 hours. The speakers are blood regulators from the Blood Regulators Network, as well as from American Association of Blood Banks (AABB), International Haemovigilance Network (IHN) and Paul Ehrlich Institute (PEI) Blood Train. Page 2 of 2 ORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ WELTGESUNDHEITSORGANISATION Date: 17 July 2020 ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ REGIONAL OFFICE FOR EUROPE Ms Elen Ohov BUREAU RÉGIONAL DE L’EUROPE REGIONALBÜRO FÜR EUROPA Adviser ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО European Union Affairs and International Co- Head office: operation Department UN City, Marmorvej 51, Ministry of Social Affairs DK-2100 Copenhagen Ø, Denmark Suur-Ameerika 1 Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01 Email: [email protected] Tallinn 10122 Website: http://www.euro.who.int Estonia Email: [email protected] Dear Ms Ohov, WHO live webinar on strengthening blood systems through effective blood regulation 3–6 August 2020 We have the honour to inform you that the World Health Organization is holding a live webinar on strengthening blood systems through effective blood regulation from 3 to 6 August 2020. The speakers in the webinar are blood regulators from the Blood Regulators Network and from the American Association of Blood Banks (AABB), the International Haemovigilance Network (IHN) and the Paul-Ehrlich-Institute (PEI) BloodTrain. The webinar language will be English, with simultaneous translation into the other five WHO official languages. The recordings of the webinar and all relevant information will be posted on the website. Each day, the webinar will start at 13:00 and end at 16:00 CET. I have pleasure in inviting you to nominate three participants from your country, representing the following institutions: • blood regulatory official from the Ministry of Health • person responsible for national blood programmes • directors of the major blood establishments. We look forward to receiving your nominations, stating the names, functional titles and contact details (including e-mail address) of the proposed participants, at the latest by 27 July 2020. The required information should be directed to Dorina Pirgari ([email protected]), Health Technologies and Pharmaceuticals Programme, WHO Regional Office for Europe. We will then communicate with the participants directly and provide them with the necessary documentation and administrative information in good time. UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email: [email protected] DK-2100 Copenhagen Ø Fax: +45 45 33 70 01 Website: http://www.euro.who.int Denmark Should you have questions or need any further information, please do not hesitate to contact us. Yours faithfully, Dr Natasha Azzopardi Muscat Director Division of Country Health Policies and Systems Copy for information to: Ms Triin Uusberg, Head, European and International Coordination Department, Ministry of Social Affairs, Suur-Ameerika 1, Tallinn 10129, Estonia, Email: [email protected], [email protected] H.E. Ms Katrin Saarsalu-Layachi, Ambassador Extraordinary and Plenipotentiary, Permanent Representative, Permanent Mission of the Republic of Estonia to the United Nations Office and other international organizations in Geneva, Chemin du Petit-Saconnex 28A, Genève CH-1209, Switzerland, Email: [email protected] H.E. Mr William Mart Laanemäe, Ambassador Extraordinary and Plenipotentiary, agréé, Embassy of the Republic of Estonia, Frederiksgade 19, 4th floor, Copenhagen K 1265, Denmark, Email: [email protected] Ms Marge Reinap, Head of WHO Office, a.i., WHO Country Office, Estonia, Paldiski Road 81, Tallinn 10617, Estonia, Email: [email protected], [email protected] –2– Saatja: LINDHARDT, Lisbeth Sjaelborg <[email protected]> Saadetud: 20.07.2020 15:17 Adressaat: Elen Ohov <[email protected]> Koopia: Triin Uusberg <[email protected]>; SM Info <[email protected]>; <[email protected]>; <[email protected]>; REINAP, Marge <[email protected]>; POLISHCHUK, Olexandr <[email protected]>; PIRGARI, Dorina <[email protected]>; LINDHARDT, Lisbeth Sjaelborg <[email protected]> Teema: EST WHO live webinar on strengthening blood systems 3-6 August 2020 Please see the attached correspondence sent from the World Health Organization, Regional Office for Europe. One or more attachments may be included.Veuillez vous r¨¦f¨¦rer ¨¤ la correspondance ci-jointe du Bureau r¨¦gional de l'Europe de l'Organisation mondiale de la sant¨¦. Une ou plusieurs annexes peuvent ¨ºtre jointes.Mit der Bitte um Kenntnisnahme der beiliegenden Korrespondenz (eine oder mehrere Anlagen), Weltgesundheitsorganisation, Regionalb¨¹ro f¨¹r Europa.§³§Þ. §á§â§Ú§Ü§â§Ö§á§Ý§Ö§ß§ß§í§Ö §á§Ú§ã§î§Þ§Ñ §à§ä §¦§Ó§â§à§á§Ö§Û§ã§Ü§à§Ô§à §â§Ö§Ô§Ú§à§ß§Ñ§Ý§î§ß§à§Ô§à §Ò§ð§â§à §£§ã§Ö§Þ§Ú§â§ß§à§Û §à§â§Ô§Ñ§ß§Ú§Ù§Ñ§è§Ú§Ú §Ù§Õ§â§Ñ§Ó§à§à§ç§â§Ñ§ß§Ö§ß§Ú§ñ (§à§Õ§Ú§ß §Ú§Ý§Ú §ß§Ö§ã§Ü§à§Ý§î§Ü§à §á§â§Ú§Ü§â§Ö§á§Ý§Ö§ß§ß§í§ç §æ§Ñ§Û§Ý§à§Ó). Best regards, Lisbeth Lindhardt Health Technologies and Pharmaceuticals Programme WHO Regional Office for Europe Office 1.2.07 Ext 7 6764 HTP annual report 2019:
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel